Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for ...
Oral vancomycin therapy resulted in clinical response in nearly half of patients with inflammatory bowel disease associated ...
A common antibiotic prescribed for infective diarrhea may also be effective in treating a specific type of inflammatory bowel disease (IBD), according to the latest research.
A commonly used antibiotic called vancomycin, which is usually prescribed to treat infectious diarrhea, may also be helpful ...
In a recent study published in the Journal of Crohn’s and Colitis, researchers showed that oral vancomycin (OV) induces clinical remission in primary sclerosing cholangitis-associated inflammatory ...
Researchers have found in a new study that common antibiotic Vancomycin may also be effective in treating individuals with a ...
The inflammatory bowel disease (IBD), develops due to an incurable autoimmune liver disease called primary sclerosing ...
A study led by the University of Birmingham found that vancomycin, a commonly used antibiotic for diarrhea, could effectively ...
Vancomycin could offer new therapeutic option for patients with a type of inflammatory bowel disease
An antibiotic used to treat infective diarrhoea could be an effective drug for a type of inflammatory bowel disease, a new study has found.
Results published in the Journal of Crohn's and Colitis revealed that an antibiotic called vancomycin may also be effective ...
An antibiotic used to treat infective diarrhea could be an effective drug for a type of inflammatory bowel disease, a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback